2 completed, 1 not yet recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Acute Ischemic Stroke (AIS): new trials by email Literature Review of Acute Ischemic Stroke (AIS) trials Research Report on Acute Ischemic Stroke (AIS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial Tirzepatide, Standard Medical Care (SMC) - Acute Ischemic Stroke (AIS) | Phase 2 / Phase 3 | Not yet recruiting | yifang zhu | 726 | 2026-09-20 | 2026-10-01 |
| Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke Placebo, scp776 (1.9 mg/kg), scp776 (3.8 mg/kg) - Acute Ischemic Stroke (AIS) | Phase 2 | Completed | Silver Creek Pharmaceuticals | 120 | 2022-10-19 | 2026-02-24 |
| Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke MCI-186, Placebo - Acute Ischemic Stroke (AIS) | Phase 2 | Completed | Shionogi | 36 | 2009-02-28 | 2026-07-16 |
Ischemic Stroke (3) · Stroke (1)
Brain Diseases (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Nervous System Diseases (3) · Vascular Diseases (3) · Stroke (2)
Edaravone (1) · Tirzepatide (1)
Shionogi (1) · Silver Creek Pharmaceuticals (1) · yifang zhu (1)
China (1) · Finland (1) · Netherlands (1) · United Kingdom (1) · United States (1)
PMID 24135530, PMID 25671797, PMID 26898852, PMID 27296974, PMID 28052979, PMID 29129157, PMID 29364767, PMID 29402504, PMID 30878104, PMID 31662037, PMID 34170647, PMID 34647404, PMID 35259929, PMID 36372278, PMID 37952131, PMID 39536238, PMID 40702450, PMID 40886075, PMID 41392086, PMID 41500725